ClinicalTrials.gg
Not yet recruitingNCT07878819Updated Oct 21, 2026

Effect of a Telerehabilitation-Supported, Family-Centered Early Intervention Program on Neurodevelopmental and Parental Outcomes in Infants at Mild-to-Moderate Risk

An interventional study of Remote Family-Centered Early Intervention Program and Standard Information and Routine Follow-up in Development Delay, Motor Skills Disorders and Neurodevelomental Disorders, sponsored by Bengisu Boz Gürboğa. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Months to 10 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Bengisu Boz Gürboğa · Not applicable, Interventional, and Prevention

Updated Oct 21, 2026Eligibility revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
6 Months to 10 Months
Sex
All
01

Study summary

The goal of this pilot randomized controlled trial is to learn whether a family-centered early intervention program, delivered remotely to parents and carried out at home, can support the development of infants who were treated in a neonatal intensive care unit (NICU) and are at mild-to-moderate developmental risk (for example, due to preterm birth or low birth weight). The study will also look at whether the program helps parents' stress and well-being.

The main questions it aims to answer are:

Does the remote family-centered early intervention program improve infants' motor, cognitive, language, and neurological development compared with standard care? Does the program reduce parental stress and anxiety and improve parents' perception of family-centered care?

Researchers will compare an intervention group with a control group receiving standard information and routine follow-up, to see whether the program leads to better infant and parent outcomes. The study will include 36 infants (18 per group) with a corrected age of 6 to 10 months.

Participants in the intervention group will:

Attend weekly online sessions with the research team for 10 weeks Carry out a home-based developmental activity program with their infant Share short videos of home practice and receive feedback, with follow-up via messaging

Participants in the control group will receive standard information and routine follow-up.

Infant development will be assessed with the Bayley-III and SINDA, and parents will complete questionnaires on stress, anxiety, and family-centered care. Assessors will be blinded to group assignment.

Read the detailed description

Background and rationale

Infants discharged from the neonatal intensive care unit (NICU) are at increased risk of developmental delays, even when their medical risk is classified as mild or moderate. Early intervention during the first year of life, when brain plasticity is high, may help reduce these risks. Family-centered approaches, in which parents are supported to integrate developmental activities into daily routines, are recommended, but access to regular in-person services is often limited by distance, cost, and the burden of frequent hospital visits. Parents of NICU graduates also commonly experience elevated stress and anxiety, which can affect parent-infant interaction and, in turn, infant development. Remote delivery (telehealth) offers a way to provide structured, family-centered support at home, but evidence on its feasibility and effects in this population is limited. This pilot trial is designed to generate preliminary data on the effects of such a program and to inform the design of a larger trial.

Intervention

The intervention is the ÇAPA family-centered early intervention program, developed by the study team. The program consists of [number] modules addressing [e.g., motor development, sensory and cognitive development, communication and language] and a psychosocial module (Module C) focused on parental well-being, coping with stress, and supporting parent-infant interaction. Module C is delivered by a psychologist and is supported by animated educational videos developed for the program.

Over 8 weeks, families in the intervention group take part in weekly online sessions in which the therapist reviews the infant's progress, demonstrates activities, and adapts the home program to the infant's needs. Between sessions, parents carry out the home program as part of daily routines and send short video recordings of practice; the therapist provides individualized feedback on these videos. Ongoing contact and reminders are maintained through a messaging application.

The control group receives standard information about infant development and continues routine follow-up care.

Study procedures

The study is conducted at [Esnaf Hospital, Istanbul, Türkiye]. After eligibility screening and informed consent, baseline assessments are performed, and infants are randomly allocated in a 1:1 ratio to the intervention or control group using [randomization method, e.g., computer-generated block randomization with sealed opaque envelopes]. Outcome assessments are performed at baseline and [after the 10-week intervention period / follow-up time point] by an assessor blinded to group allocation.

Pilot objectives

In addition to estimating the effects of the program, this pilot study will evaluate feasibility indicators, including [recruitment rate, retention, session attendance, adherence to the home program, and parent satisfaction], to inform sample size calculation and procedures for a future definitive trial.

02

Conditions studied

  • Development Delay
  • Motor Skills Disorders
  • Neurodevelomental Disorders
  • High Risk Infant
  • Premature Birth
03

In context

Learning Disabilities

150 studies on the registry are indexed under Learning Disabilities; 51 are open to participants now.

This study's planned enrollment of 36 is below the median of 60 across 101 interventional studies indexed under Learning Disabilities.

Browse Learning Disabilities studies →

Lead sponsor

This is the only study on the registry with Bengisu Boz Gürboğa as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 10 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Corrected age of 6 to 10 months
  • Mild or moderate risk group according to the Turkish Neonatology Society High-Risk Infant Follow-up Guideline
  • History of neonatal intensive care unit admission
  • Written informed consent from the family
  • Caregiver able to carry out the home program
  • Family access to telephone, internet, and a computer or tablet
  • Family agrees to attend remote follow-up sessions

Exclusion criteria

Exclusion Criteria:

  • High risk group according to the Turkish Neonatology Society High-Risk Infant Follow-up Guideline
  • Birth weight below 1000 g
  • Gestational age below 29 weeks
  • History of grade 3-4 intracranial hemorrhage
  • History of cystic periventricular leukomalacia
  • Hydrocephalus, cerebral infarction, or severe central nervous system pathology
  • History of seizures or uncontrolled epilepsy
  • Markedly abnormal neurological examination at discharge
  • Need for advanced resuscitation at birth
  • History of prolonged mechanical ventilation
  • History of bronchopulmonary dysplasia, severe apnea, or pneumothorax
  • Severe visual or hearing impairment
  • Congenital anomaly or severe systemic disease
  • Currently attending another rehabilitation program
  • Communication or language barrier that prevents reliable intervention and assessment and cannot be resolved with accessible arrangements
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Remote Family-Centered Early Intervention

    Infants and their parents receive the 8-week CAPA remote family-centered early intervention program in addition to routine follow-up. The program includes weekly online sessions with a therapist, a home-based developmental activity program integrated into daily routines, and individualized feedback on short videos of home practice recorded by parents. Parents also receive a psychosocial education module, delivered by a psychologist and supported by animated educational videos, focusing on parental well-being, coping with stress, and parent-infant interaction. Ongoing contact and reminders are provided via a messaging application.

    Behavioral: Remote Family-Centered Early Intervention Program

  • Active comparator
    Standard Care

    Infants and their parents receive standard written/verbal information about infant development and continue routine follow-up care at the hospital. No additional intervention is provided during the study period.

    Behavioral: Standard Information and Routine Follow-up

Interventions

  • BehavioralRemote Family-Centered Early Intervention Program

    The CAPA program is a 8-week, family-centered early intervention delivered remotely to parents of infants discharged from the NICU at mild-to-moderate developmental risk. Unlike clinic-based therapist-delivered interventions, parents are coached to carry out developmental activities within the infant's daily routines at home. Components: 1. 3 individual online video sessions with a therapist, in which the infant's progress is reviewed, activities are demonstrated, and the home program is individually adapted to the infant's developmental needs; 2. A structured home program targeting motor, cognitive, sensory, and communication/language development, which parents are asked to practice 3. Video-based feedback: parents record short videos of home practice \[weekly\] and receive individualized written/verbal feedback from the therapist; 4. A psychosocial education module (Module C), delivered by a psychologist and support

  • BehavioralStandard Information and Routine Follow-up

    Families receive standard information about typical infant development and general recommendations for supporting development at home, provided \[verbally and/or as a written brochure\] at enrollment. Infants continue routine follow-up care at the hospital's high-risk infant follow-up clinic as usual. No structured home program, online sessions, video-based feedback, psychosocial education module, or messaging-based follow-up is provided during the study period.

06

What researchers measure

Primary outcomes

  1. Change in Bayley Motor Scales of Infant and Toddler Development, Third Edition (Bayley-III) Composite Scores

    Infant development will be assessed with the Bayley-III by a blinded assessor. Cognitive, Language, and Motor composite scores will be calculated (each with a mean of 100 and a standard deviation of 15; range 40-160). Higher scores indicate better developmental performance. Change from baseline to post-intervention will be compared between groups.

    Time frame: 8 weeks

07

Study locations

1 site
  • Istanbul University
    Istanbul, Fatih 34093, Turkey (Türkiye)
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

Of 55 non-industry interventional studies with no phase under Learning Disabilities, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 49. This study's planned 5 months is below that.

Counting every sponsor, half of 58 studies reached it within 30 months; a quarter within 7 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 11, 2026
First posted
Oct 16, 2026
StartEst.
Nov 16, 2026
Primary completionEst.
Apr 27, 2027
CompletionEst.
May 15, 2027
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility
Registered
First appeared on the registry
Oct 16, 2026
Show all 2 updates
  1. Oct 21, 2026
    Eligibility Criteria revised
    + 2 other changes: index terms and conditions
  2. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07878819
Lead sponsor
Bengisu Boz Gürboğa
Responsible party
Bengisu Boz Gürboğa (Physiotherapist, Psychologist, Istanbul University) — Sponsor-investigator
First posted
Oct 16, 2026
Start date
Nov 16, 2026 (estimated)
Primary completion
Apr 27, 2027 (estimated)
Completion
May 15, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Bengisu Boz Gürboğa, bachelor
Contact
bengisuboz99@gmail.com
+905309300499
Ayşe Resa Aydın, professor
principal investigator · Istanbul University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion